Neutrophil-depleted platelet rich plasma formulations for cardiac treatments
View Patent ↗Compositions and methods for preparing neutrophil-depleted platelet rich plasma are provided. Generally, these compositions comprise a higher concentration of platelets and depressed concentrations of neutrophils relative to whole blood although white blood cells may be at higher concentrations than whole blood. The concentrations of the platelets and/or the white blood cells may be two to eight times the respective concentrations in whole blood. These compositions may have depressed concentrations of red blood cells and hemoglobin. In some variations, the compositions may be useful to treat damaged connective tissue and/or to slow or stop cardiac apoptosis after a heart attack. The neutrophil-depleted platelet rich plasma composition may be delivered in conjunction with reperfusion therapy.
1. A composition comprising:
platelets in a concentration of about 500,000/μl to about 7,000,000/μl,
monocytes in a concentration of about 400/μl to about 3200/μl, and
neutrophils in a concentration of less than about 5000/μl,
lymphocytes in a concentration of about 2600/μl to about 16000/μl,
wherein the composition does not include an exogenous activator.
2. The composition of claim 1 , wherein the concentration of platelets is between about 600,000 platelets/μl and about 5,000,000 platelets/μl.
3. The composition of claim 1 , wherein the concentration of platelets is between about 700,000 platelets/μl and about 2,500,000 platelets/μl.
4. The composition of claim 1 , wherein the concentration of platelets is between about 900,000 platelets/μl and about 1,500,000 platelets/μl.
5. The composition of claim 1 , wherein the concentration of neutrophils is less than about 1000/μl.
6. The composition of claim 1 , wherein the hemoglobin concentration is about 1.0 g/dL to about 5 g/dL.
7. The composition of claim 1 , wherein the hemoglobin concentration is 1 g/dL or less.
8. A method of preparing the composition of claim 1 comprising:
mixing components from a starting material to obtain the composition, wherein the starting material comprises at least in part whole blood, said composition comprising:
platelets in a concentration of about 500,000/μl to about 7,000,000/μl,
monocytes in a concentration of about 400/μl to about 3200/μl,
lymphocytes in a concentration of about 2600/μl to about 16000/μl and
neutrophils in a concentration of less than about 5000/μl.
9. The method of claim 8 , wherein the platelet concentration is between 2-8 times the platelet concentration in the starting material.
10. The method of claim 8 , wherein the neutrophil concentration is less than about 1000/μl.
11. A method of preparing the composition of claim 1 comprising:
mixing components from a source of whole blood to obtain the composition, said composition comprising:
platelets in a concentration of about 500,000/μl to about 7,000,000/μl,
monocytes in a concentration of about 400/μl to about 3200/μl,
lymphocytes in a concentration of about 2600/μl to about 16000/μl and
neutrophils in a concentration of less than about 5000/μl.
12. The method of claim 11 , wherein the platelet concentration is between 2-8 times the platelet concentration in the whole blood.
13. The method of claim 12 , wherein the platelet concentration is between 4-6 times the platelet concentration in the whole blood.
14. The method of claim 11 , wherein the hemoglobin concentration is less than about 3.5 grams per deciliter.
15. The method of claim 11 , wherein the neutrophil concentration is less than about 1000/μl.
16. The method of claim 11 , wherein the composition is prepared from the whole blood via centrifugation, gravity filtration, or direct cell sorting.
17. The method of claim 11 , wherein the composition further comprises:
white blood cells derived from the whole blood at a concentration of at least a white blood cell concentration in the whole blood, wherein the white blood cells comprise:
monocytes at a concentration of at least about two times a monocyte concentration in the whole blood; and
lymphocytes at a concentration of at least about two times a lymphocyte concentration in the whole blood.